List of insiders holdings for Iterum Therapeutics plc:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | New Leaf Venture Management III L.L.C. New Leaf Venture Associates III L.P. New Leaf Ventures III L.P. Lathi Vijay K Ratcliffe Liam 10% Owner |
2021-02-12 17:22:08 | 5,331,800 0 |
5,331,800 | Form 13D |
| 2 | CANAAN X L.P. Canaan Partners X LLC Director 10% Owner |
2021-02-03 14:37:59 | 1,733,170 0 |
1,733,170 | Form 13G |
| 3 | Frazier Healthcare VII L.P. Frazier Healthcare VII-A L.P. FHM VII L.P. FHM VII L.L.C. 10% Owner |
2020-10-29 13:00:51 | 1,557,158 0 |
1,557,158 | Form 13D |
| 4 | Malik Shahzad Director |
2020-01-23 16:57:44 | 0 1,548,000 |
1,548,000 | Form 4 |
| 5 | Heron Patrick J Director |
2020-07-06 06:05:18 | 9,006 1,538,316 |
1,547,322 | Form 4 |
| 6 | Kelly David George Director |
2022-06-17 17:01:35 | 647,059 0 |
647,059 | Form 4 |
| 7 | Dunne Michael W. Director |
2024-08-12 09:00:05 | 432,495 0 |
432,495 | Form 4 |
| 8 | Lathi Vijay K Ratcliffe Liam 10% Owner |
2018-05-31 16:54:17 | 0 384,615 |
384,615 | Form 4 |
| 9 | Fishman Corey N. Chief Executive Officer |
2024-08-12 09:00:04 | 302,288 0 |
302,288 | Form 4 |
| 10 | Matthews Judith M. Chief Financial Officer |
2023-04-03 20:00:18 | 100,000 0 |
100,000 | Form 4 |
| 11 | Schaffnit Jeffrey R. Chief Commercial Officer |
2018-05-29 17:08:53 | 31,826 0 |
31,826 | Form 4 |
| 12 | Edick Paul R Director |
2019-05-29 16:24:56 | 31,390 0 |
31,390 | Form 4 |
| 13 | Ahrens Brenton Karl Director |
2022-12-28 21:00:18 | 29,125 0 |
29,125 | Form 4 |
| 14 | Puttagunta Sailaja Chief Medical Officer |
2023-12-04 17:00:26 | 27,035 0 |
27,035 | Form 4 |
| 15 | Hecht Beth Director |
2023-06-15 17:00:15 | 18,839 0 |
18,839 | Form 4 |
| 16 | Chin Mark Director |
2023-06-15 17:00:10 | 18,306 0 |
18,306 | Form 4 |
| 17 | Sofinnova Venture Partners IX L.P. Sofinnova Management IX L.L.C. HEALY JAMES POWELL MICHAEL 10% Owner |
2020-06-05 16:48:01 | 6,154 0 |
6,154 | Form 13D |
| 18 | Sofinnova Venture Partners IX L.P. POWELL MICHAEL Sofinnova Management IX L.L.C. Mehra Anand 10% Owner |
2020-06-05 16:48:01 | 6,154 0 |
6,154 | Form 13D |
| 19 | HUNT RONALD Director |
2025-01-23 18:30:04 | 0 0 |
0 | Form 4 |
| 20 | Whalen Joseph John Director |
2025-03-18 08:00:04 | 0 0 |
0 | Form 3 |
| 21 | DENNER ALEXANDER J Sarissa Capital Management LP Sarissa Capital Offshore Master Fund LP Sarissa Capital Catapult Fund LLC Sarissa Capital Hawkeye Fund LP Sarissa Capital Master Fund II LP 10% Owner |
2021-02-12 20:22:13 | 0 0 |
0 | Form 4 |
| 22 | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner |
2021-02-11 16:46:28 | 0 0 |
0 | Form 13G |